Tattoo-Limited Granulomatous Reactions During BRAF/MEK Inhibition in Metastatic Melanoma: Further Clinical Experience from Two Additional Cases

Background/Objectives: Tattoo-associated inflammatory reactions during BRAF/MEK inhibitor therapy are uncommon and remain poorly characterized. Building on the case previously reported by Baratta et al., we describe two additional patients with melanoma who developed granulomatous reactions confined to pre-existing tattoos during combined BRAF/MEK inhibition. Case Presentation: Both patients were young men with advanced melanoma and developed well-demarcated eczematous and infiltrated plaques restricted to black tattooed skin. Histological examination showed non-necrotizing granulomatous dermatitis with pigment-containing histiocytes and multinucleated giant cells, consistent with a foreign-body-type reaction. In one patient the reaction remained limited to the skin, whereas the other developed systemic symptoms together with persistent laboratory abnormalities. In both scenarios 18F-FDG PET/CT also showed focal hypermetabolic activity corresponding to the tattooed areas. Conclusions: These observations add to the limited clinical experience with tattoo-restricted granulomatous reactions during BRAF/MEK inhibition. They also underline the broader immunomodulatory effects of targeted therapy and the need to recognize this uncommon adverse event in order to avoid misinterpretation and potentially unnecessary treatment changes. Further reports are needed to better define its pathogenesis and possible association with systemic toxicity or treatment response.

Authors

Institutions

Publication Details

Journal
Journal of Clinical Medicine
Published
2026-11-16
DOI
https://doi.org/10.3390/jcm15228963
Primary Topic
Melanoma and MAPK Pathways
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Tattoo-Limited Granulomatous Reactions During BRAF/MEK Inhibition in Metastatic Melanoma: Further Clinical Experience from Two Additional Cases

Giuseppe Rizzuto, Luca Filippi, Claudio Di Cristofano, Concetta Potenza et al.
Journal of Clinical Medicine
Melanoma and MAPK Pathways
article

Tattoo-Limited Granulomatous Reactions During BRAF/MEK Inhibition in Metastatic Melanoma: Further Clinical Experience from Two Additional Cases

Giuseppe Rizzuto, Luca Filippi, Claudio Di Cristofano, Concetta Potenza, Ilaria Proietti, Alberto Taliano, Steven Paul Nisticò, Luca Guarino, Vincenzo Coppolelli, Lako Kostika
article en

Abstract

Background/Objectives: Tattoo-associated inflammatory reactions during BRAF/MEK inhibitor therapy are uncommon and remain poorly characterized. Building on the case previously reported by Baratta et al., we describe two additional patients with melanoma who developed granulomatous reactions confined to pre-existing tattoos during combined BRAF/MEK inhibition. Case Presentation: Both patients were young men with advanced melanoma and developed well-demarcated eczematous and infiltrated plaques restricted to black tattooed skin. Histological examination showed non-necrotizing granulomatous dermatitis with pigment-containing histiocytes and multinucleated giant cells, consistent with a foreign-body-type reaction. In one patient the reaction remained limited to the skin, whereas the other developed systemic symptoms together with persistent laboratory abnormalities. In both scenarios 18F-FDG PET/CT also showed focal hypermetabolic activity corresponding to the tattooed areas. Conclusions: These observations add to the limited clinical experience with tattoo-restricted granulomatous reactions during BRAF/MEK inhibition. They also underline the broader immunomodulatory effects of targeted therapy and the need to recognize this uncommon adverse event in order to avoid misinterpretation and potentially unnecessary treatment changes. Further reports are needed to better define its pathogenesis and possible association with systemic toxicity or treatment response.

Journal of Clinical MedicineVol. 15(22)
University of Rome Tor Vergata (IT), Sapienza University of Rome (IT)
Melanoma and MAPK Pathways
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon